Tuesday, July 14, 2026
22.5
C
Bengaluru
Hot topics
“Sales at Any Cost” is Not Sustainable in the Long Run
For commercial organisations, profits are important. But it cannot be 'at any cost' and certainly not at the cost of human life. As healthcare providers helping to mitigate the pain and misery of millions of human beings, we need to remember that charity begins at home.
How to Influence Patients to Adopt Healthy Lifestyle or Improve Adherence?
One of the many ways of influencing patients to...
The Pill is Now a Commodity – Can ‘Beyond the Pill’ Models Work in India?
The pill is now a commodity that many of these companies provide at heavy discounts, making money off everything ‘beyond the pill’. Investors are betting heavily on the potential of technological innovation to transform the way healthcare is delivered.
The Economic Times reported that in 2021, India recorded investments of $77 billion across 1,266 deals including 164 large deals worth $58 billion. While the money reduced in 2022, the reason wasn’t a lack of faith in this business model.
Meanwhile, the pharmaceuticals industry that is most affected by this quiet but rapid change, is grappling with its entrenched culture. Its current business is so profitable that everything else pales in comparison.
‘Build, measure, learn, build again’ – a mantra of the health tech industry is alien to pharma that doesn’t learn, build or measure after launching a product.
Pharma also thinks of its customers as doctors alone and does precious little to connect with patients, or caregivers. People who are not sick do not feature on their radar at all. These are cultural values that keep pharma focused on the pill and discourage thinking beyond it.
A social media poll conducted by MedicinMan showed almost predictable responses. 100+ respondents who work in the pharma industry in India were quite clearly divided. 48% of them wanted to know what beyond the pill actually meant, while 23% wanted to know how to execute it.
The rest felt that the ultra-competitive environment in the Indian generics market required very high share-of-voice tactics (19%), or that their customers demanded product information (9%).
The ₹5 Snack SKU: A Silent Indian Metabolic Crisis
Executive Summary — The Paradox of Scale
In the annals...
Indian Pharma: Are Regulatory Gaps From Generics Following Biosimilars?
Transparency, Trust, and the Problem of “Invisible Evidence” in...
The Wealth of Pharma Nations: Top 25 Pharma Blockbusters
The economic footprint of a truly historic pharmaceutical blockbuster...
Oxytocin Maternal Deaths in Kota: Death in a Vial
When a vial contains only water, the failure is...
Innovation Without Access to Millions of Poor People is Unethical
What the Trikafta Stand-Off Teaches Us About the Future...
Dr. Rishubh Gupta has been appointed Head of Subregion Africa for Roche Diagnostics
Dr. Rishubh Gupta has been appointed Head of Subregion...
Meril Life Sciences is India’s Top Medtech Company
India's MedTech Mavericks: The Profitability Paradox: Balancing Rapid Growth...
The Wealth of Pharma Nations: Top 25 Pharma Blockbusters
The economic footprint of a truly historic pharmaceutical blockbuster...
Oxytocin Maternal Deaths in Kota: Death in a Vial
When a vial contains only water, the failure is...
Innovation Without Access to Millions of Poor People is Unethical
What the Trikafta Stand-Off Teaches Us About the Future...
Dr. Rishubh Gupta has been appointed Head of Subregion Africa for Roche Diagnostics
Dr. Rishubh Gupta has been appointed Head of Subregion...
Meril Life Sciences is India’s Top Medtech Company
India's MedTech Mavericks: The Profitability Paradox: Balancing Rapid Growth...
The Wealth of Pharma Nations: Top 25 Pharma Blockbusters
The economic footprint of a truly historic pharmaceutical blockbuster...
Oxytocin Maternal Deaths in Kota: Death in a Vial
When a vial contains only water, the failure is...
Innovation Without Access to Millions of Poor People is Unethical
What the Trikafta Stand-Off Teaches Us About the Future...
Dr. Rishubh Gupta has been appointed Head of Subregion Africa for Roche Diagnostics
Dr. Rishubh Gupta has been appointed Head of Subregion...
Meril Life Sciences is India’s Top Medtech Company
India's MedTech Mavericks: The Profitability Paradox: Balancing Rapid Growth...
The Wealth of Pharma Nations: Top 25 Pharma Blockbusters
The economic footprint of a truly historic pharmaceutical blockbuster...
Oxytocin Maternal Deaths in Kota: Death in a Vial
When a vial contains only water, the failure is...
Innovation Without Access to Millions of Poor People is Unethical
What the Trikafta Stand-Off Teaches Us About the Future...
Dr. Rishubh Gupta has been appointed Head of Subregion Africa for Roche Diagnostics
Dr. Rishubh Gupta has been appointed Head of Subregion...
Meril Life Sciences is India’s Top Medtech Company
India's MedTech Mavericks: The Profitability Paradox: Balancing Rapid Growth...
Hot topics
Dr. Peter Velev, CEO of CredoWeb discussing Digital in Pharma with MedicinMan
The digital revolution is the fourth industrial revolution. It changes models, processes and whole public sectors. In many reports you will find that, in terms of digitalization, pharma is just next to the public sector, as least digitalized. Pharma just started late. There are many reasons for that – it is one of the most regulated industries with lots of sensitive data involved and many ethical aspects. But the slowed down digitalization has a lot to do with some subjective reasons. Adopting digital technologies requires changing existing models which requires a different mindset – and this is difficult to achieve. Nowadays, in the situation of a global pandemic, we see that digital communication is not only necessary to be successful but it is a must in order to adapt to the New Normality.
3 Rules of the Digital World for Pharma Brand Managers
The first time I heard the term ‘digital economy’...
Oracle Debacle – Midlife Reinvention is an Al Generated Orwellian Lie
A Tale of Two Truths: Severance, Up in the...
How to Harness the Power of Omnichannel Marketing in the Pharma Industry
Pharmaceutical & medical devices Industry is fast adapting to these changes at various levels of the value chain. Billions of dollars are being spent on digital transformation projects ranging from usage of AI & ML in product development, production and predictive maintenance, Blockchain in supply chain and data management & analytics in strategic decision making.
This article focuses on Omnichannel marketing, one of the key digital transformations that the industry is learning and implementing at a rapid pace.
Omnichannel Marketing: Promise and Possibilities
An industry that historically focused all their brand building and market shaping efforts through F2F meetings & medical education programs has started making giant strides in multi-channel strategy now.
A digital journey that started with an e-detailing platform has progressed fast by adding brand websites, Approved E-Mails, social media, webinars and other media effectively creating a multi-channel strategy. The only hindside to this is, all these channels work independently, expecting HCPs to find and sort out information themselves.
The Killer Nexus – What Really Ails Indian Healthcare?
For Every Bottle Of Killer Cough Syrup Doctor Prescribed,...
The Wealth of Pharma Nations: Top 25 Pharma Blockbusters
The economic footprint of a truly historic pharmaceutical blockbuster...
Oxytocin Maternal Deaths in Kota: Death in a Vial
When a vial contains only water, the failure is...
Innovation Without Access to Millions of Poor People is Unethical
What the Trikafta Stand-Off Teaches Us About the Future...
Dr. Rishubh Gupta has been appointed Head of Subregion Africa for Roche Diagnostics
Dr. Rishubh Gupta has been appointed Head of Subregion...
Meril Life Sciences is India’s Top Medtech Company
India's MedTech Mavericks: The Profitability Paradox: Balancing Rapid Growth...
The Wealth of Pharma Nations: Top 25 Pharma Blockbusters
The economic footprint of a truly historic pharmaceutical blockbuster...
Oxytocin Maternal Deaths in Kota: Death in a Vial
When a vial contains only water, the failure is...
Innovation Without Access to Millions of Poor People is Unethical
What the Trikafta Stand-Off Teaches Us About the Future...
Dr. Rishubh Gupta has been appointed Head of Subregion Africa for Roche Diagnostics
Dr. Rishubh Gupta has been appointed Head of Subregion...
Meril Life Sciences is India’s Top Medtech Company
India's MedTech Mavericks: The Profitability Paradox: Balancing Rapid Growth...
The Wealth of Pharma Nations: Top 25 Pharma Blockbusters
The economic footprint of a truly historic pharmaceutical blockbuster...
Oxytocin Maternal Deaths in Kota: Death in a Vial
When a vial contains only water, the failure is...
Innovation Without Access to Millions of Poor People is Unethical
What the Trikafta Stand-Off Teaches Us About the Future...
Dr. Rishubh Gupta has been appointed Head of Subregion Africa for Roche Diagnostics
Dr. Rishubh Gupta has been appointed Head of Subregion...
Meril Life Sciences is India’s Top Medtech Company
India's MedTech Mavericks: The Profitability Paradox: Balancing Rapid Growth...
The Wealth of Pharma Nations: Top 25 Pharma Blockbusters
The economic footprint of a truly historic pharmaceutical blockbuster...
Oxytocin Maternal Deaths in Kota: Death in a Vial
When a vial contains only water, the failure is...
Innovation Without Access to Millions of Poor People is Unethical
What the Trikafta Stand-Off Teaches Us About the Future...
Dr. Rishubh Gupta has been appointed Head of Subregion Africa for Roche Diagnostics
Dr. Rishubh Gupta has been appointed Head of Subregion...
Meril Life Sciences is India’s Top Medtech Company
India's MedTech Mavericks: The Profitability Paradox: Balancing Rapid Growth...
MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More
Headlines
The Wealth of Pharma Nations: Top 25 Pharma Blockbusters
The economic footprint of a truly historic pharmaceutical blockbuster...
Oxytocin Maternal Deaths in Kota: Death in a Vial
When a vial contains only water, the failure is...
Innovation Without Access to Millions of Poor People is Unethical
What the Trikafta Stand-Off Teaches Us About the Future...
Dr. Rishubh Gupta has been appointed Head of Subregion Africa for Roche Diagnostics
Dr. Rishubh Gupta has been appointed Head of Subregion...
Newsletter
Get important news delivered directly to your inbox and stay connected!